Nicotine Use Clinical Trials

12 recruitingLast updated: May 21, 2026

There are 12 actively recruiting nicotine use clinical trials across 4 countries. Studies span Not Applicable, Phase 4, Phase 1, Phase 2. Top locations include Newark, New Jersey, United States, Toronto, Ontario, Canada, Gainesville, Florida, United States. Updated daily from ClinicalTrials.gov.


Nicotine Use Trials at a Glance

12 actively recruiting trials for nicotine use are listed on ClinicalTrialsFinder across 6 cities in 4 countries. The largest study group is Not Applicable with 7 trials, with the heaviest enrollment activity in Newark, Toronto, and Gainesville. Lead sponsors running nicotine use studies include Centre for Addiction and Mental Health, Rutgers, The State University of New Jersey, and Overcome.

Browse nicotine use trials by phase

About Nicotine Use Clinical Trials

Looking for clinical trials for Nicotine Use? There are currently 1 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Nicotine Use trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Nicotine Use clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 112 of 12 trials

Recruiting
Not Applicable

Developing a Scalable Tobacco Cessation Program for Cancer Survivors and Caregivers

Tobacco UseNicotine Use
University of Florida204 enrolled1 locationNCT06851936
Recruiting
Not Applicable

Implementation of Tobacco Cessation Programming at Community Behavioral Health Sites

Smoking CessationNicotine Use DisorderSmoking Cessation Intervention
University of Chicago24 enrolled1 locationNCT06837220
Recruiting
Phase 1

Testing the Feasibility and Acceptability of Social Media and Digital Therapeutics to Decrease Vaping Behaviors

Nicotine Use DisorderNicotine Vaping
Washington University School of Medicine189 enrolled1 locationNCT05994209
Recruiting
Phase 4

Smoking Cessation and Menstrual Cycle Phase

Smoking CessationSubstance Use DisordersNicotine Dependence+2 more
Centre for Addiction and Mental Health1,200 enrolled1 locationNCT05515354
Recruiting
Not Applicable

Temporal Interference Methods for Addiction Treatment

Substance Use DisordersNicotine Use Disorder
Indiana University120 enrolled1 locationNCT07210268
Recruiting
Not Applicable

Effects of Novel E-cigarette Constituents on Adults TCORS 3.0

Nicotine Use Disorder
Yale University66 enrolled1 locationNCT05932745
Recruiting
Not Applicable

Identify the Optimal TMS Target to Modulate Reward Activity

Nicotine Use Disorder
Rutgers, The State University of New Jersey36 enrolled1 locationNCT05766254
Recruiting
Not Applicable

Identify the Optimal TMS Pulse Protocol to Modulate Reward Activity

Nicotine Use Disorder
Rutgers, The State University of New Jersey42 enrolled1 locationNCT06695884
Recruiting
Phase 4

tDCS Plus Varenicline for Smoking Cessation

Smoking CessationTobacco Use DisorderSubstance Use Disorders+3 more
Centre for Addiction and Mental Health160 enrolled1 locationNCT06798324
Recruiting

The Pitjantjatjara ASSIST: A project aimed at assessing the validity, reliability and cultural appropriateness of the digital, translated and culturally-adapted Alcohol, Smoking and Substance Involvement Screening Test (ASSIST), for use in Aboriginal and Torres Strait Islander populations.

inhalants dependenceharmful use of alcoholharmful use of cannabis+10 more
The University of Adelaide600 enrolled1 locationACTRN12625000413426
Recruiting
Not Applicable

Real-time eCounselling for Nicotine Addiction

Nicotine Use Disorder
Overcome60 enrolled1 locationNCT06544057
Recruiting
Phase 2

Pharmaceutically-Enhanced Reinforcement for Reduced Alcohol and Smoking

Nicotine Use DisorderAlcohol Use Disorder (AUD)
Washington State University205 enrolled1 locationNCT05181891